Beta-Blockers and Abdominal Aortic Aneurysm Growth: A Systematic Review and Meta-Analysis
Overview
Authors
Affiliations
Background: Aortic aneurysms are worrisome because of their predisposition to dissection and rupture. Beta-blockers are considered first-line therapy for aortic aneurysms. The following meta-analysis assesses if beta-blockers diminish aortic aneurysm growth.
Methods: A literature search was performed to collect information on clinical trials that have assessed aortic aneurysm growth between beta-blockers and placebo. The primary endpoint was aortic aneurysm growth rate per year. A forest plot with a random-effects model was used for analysis.
Results: Eight clinical trials were included in the analysis. Beta-blockers showed a statistically non-significant effect on aortic aneurysm growth (standard mean difference -0.44; 95% CI [-0.44, 0.00]).
Conclusion: Beta-blockers do not significantly influence aortic aneurysm growth. Further studies are required to find a suitable medical therapy to reduce growth rates.
Circ_0000006 and circ_0000160 regulate hsa-let-7e-5p/UBQLN4 axis in aortic dissection progression.
Liu Y, Wang L, Lei D, Tan X, Jin W, Hou M PLoS One. 2024; 19(5):e0304668.
PMID: 38820386 PMC: 11142605. DOI: 10.1371/journal.pone.0304668.
Shu T, Zhou Y, Yan C Vascul Pharmacol. 2024; 154:107278.
PMID: 38262506 PMC: 10939884. DOI: 10.1016/j.vph.2024.107278.
CT analysis of aortic calcifications to predict abdominal aortic aneurysm rupture.
Mansouri M, Therasse E, Montagnon E, Zhan Y, Lessard S, Roy A Eur Radiol. 2023; 34(6):3903-3911.
PMID: 37999728 DOI: 10.1007/s00330-023-10429-1.
Wang Y, Sargisson O, Nguyen D, Parker K, Pyke S, Alramahi A Int J Mol Sci. 2023; 24(21).
PMID: 37958938 PMC: 10650676. DOI: 10.3390/ijms242115955.
Rezaeitaleshmahalleh M, Mu N, Lyu Z, Zhou W, Zhang X, Rasmussen T J Cardiovasc Transl Res. 2023; 16(5):1123-1134.
PMID: 37407866 DOI: 10.1007/s12265-023-10404-7.